Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome
M. Ge, J. Molina, J. J. Kim…·A. Fornoni
This study shows empagliflozin reduces renal lipotoxicity and improves kidney function in experimental Alport syndrome by shifting energy substrates from glucose to fatty acids in podocytes.